• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量放射性碘治疗甲状腺癌的中长期副作用

Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma.

作者信息

Alexander C, Bader J B, Schaefer A, Finke C, Kirsch C M

机构信息

Department of Nuclear Medicine, Saarland University Medical Center, Homburg/Saar, Germany.

出版信息

J Nucl Med. 1998 Sep;39(9):1551-4.

PMID:9744341
Abstract

UNLABELLED

The present investigation is an evaluation of intermediate and long-term side effects in patients after high-dose radioiodine treatment due to differentiated thyroid carcinoma.

METHODS

A total of 203 patients were interviewed using a standardized questionnaire.

RESULTS

After radioiodine treatment, 76.8% of the patients reported intermediate (from discharge up to 3 mo) or long-term (more than 3 mo after treatment) complaints, and 61.1% reported long-term side effects. Nonstochastic side effects included sialoadenitis, which occurred in 33.0% of cases, and 27.1% of patients suffered from a transient loss of taste or smell. More than 1 yr after the last radioiodine application, 42.9% of patients suffered from reduced salivary gland function. Complete xerostomia occurred in 4.4% of patients. Hematological abnormalities were found in 9 patients. In 28.1% of patients a transient episode of alopecia was reported. In 22.7% of patients chronic or recurrent conjunctivitis was reported, and 4 patients underwent dacryocystorhinostomy; 13.8% of patients suffered from an increased frequency of influenza, but 3.4% reported a reduced occurrence of such infections. For sialoadenitis, the loss of taste/smell and dry mouth, the dependence on accumulated activity was significant.

CONCLUSION

Severe long-term side effects are rare after high-dose radioiodine treatment. Moderate side effects are common. The side effects are commonly the result of radiation damage to the salivary glands. The frequency of such complaints advocates regular protection of the salivary glands.

摘要

未标注

本研究旨在评估分化型甲状腺癌患者接受高剂量放射性碘治疗后的中长期副作用。

方法

使用标准化问卷对203例患者进行访谈。

结果

放射性碘治疗后,76.8%的患者报告有中期(出院至3个月)或长期(治疗后3个月以上)不适,61.1%的患者报告有长期副作用。非随机副作用包括涎腺炎,发生率为33.0%,27.1%的患者有短暂味觉或嗅觉丧失。最后一次应用放射性碘1年多后,42.9%的患者唾液腺功能减退。4.4%的患者出现完全性口干。9例患者发现血液学异常。28.1%的患者报告有短暂脱发。22.7%的患者报告有慢性或复发性结膜炎,4例患者接受了泪囊鼻腔吻合术;13.8%的患者流感发作频率增加,但3.4%的患者报告此类感染发生率降低。对于涎腺炎、味觉/嗅觉丧失和口干,与累积活度的相关性显著。

结论

高剂量放射性碘治疗后严重的长期副作用罕见。中度副作用常见。副作用通常是唾液腺辐射损伤的结果。此类不适的发生率表明应定期保护唾液腺。

相似文献

1
Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma.大剂量放射性碘治疗甲状腺癌的中长期副作用
J Nucl Med. 1998 Sep;39(9):1551-4.
2
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?柠檬糖能否降低甲状腺癌放射性碘治疗后的唾液腺损伤?
J Nucl Med. 2005 Feb;46(2):261-6.
3
Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.唾液腺副作用通常在首次放射性碘消融术后数周出现。
J Nucl Med. 2009 Oct;50(10):1605-10. doi: 10.2967/jnumed.108.061382. Epub 2009 Sep 16.
4
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.青少年分化型甲状腺癌及其放射性碘在治疗中的作用:一项定性综述。
Endocr Relat Cancer. 2005 Dec;12(4):773-803. doi: 10.1677/erc.1.00880.
5
Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study.放射性碘治疗后泪腺的长期损害:一项横断面研究。
Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1428-32. doi: 10.1007/s00259-002-0969-0. Epub 2002 Aug 28.
6
Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma.“合理剂量”碘-131治疗转移性分化型甲状腺癌的副作用。
J Nucl Med. 1986 Oct;27(10):1519-27.
7
Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.甲状腺癌患者放射性碘治疗后唾液腺功能的迟发副作用。
Head Neck. 2011 May;33(5):686-90. doi: 10.1002/hed.21520. Epub 2010 Nov 10.
8
Sialoadenitis secondary to ¹³¹I therapy for well-differentiated thyroid cancer.放射性¹³¹I 治疗分化型甲状腺癌继发唾液腺炎。
Oral Dis. 2011 Mar;17(2):154-61. doi: 10.1111/j.1601-0825.2010.01726.x. Epub 2010 Oct 28.
9
Treatment for microcarcinoma of the thyroid--clinical experience.甲状腺微小癌的治疗——临床经验
Clin Nucl Med. 2007 Apr;32(4):279-81. doi: 10.1097/01.rlu.0000257272.90126.3d.
10
Interventional sialendoscopy for treatment of radioiodine-induced sialadenitis.介入性涎腺内镜治疗放射性碘诱发的涎腺炎。
Laryngoscope. 2009 May;119(5):864-7. doi: 10.1002/lary.20140.

引用本文的文献

1
[Ga]Ga-FAPI-04 PET/CT in the evaluation of radiation-induced salivary gland injury in head and neck cancer.[镓]镓-FAPI-04 PET/CT在评估头颈部癌放射性唾液腺损伤中的应用
Eur J Nucl Med Mol Imaging. 2025 Aug 12. doi: 10.1007/s00259-025-07486-7.
2
The Impact of Radioiodine (131I) Therapy of Thyroid Disease on Salivary Glands Function and Inflammation: A Comprehensive Review.放射性碘(¹³¹I)治疗甲状腺疾病对唾液腺功能和炎症的影响:综述
Biomedicines. 2025 Jun 7;13(6):1404. doi: 10.3390/biomedicines13061404.
3
Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation.
低剂量与标准剂量放射性碘治疗分化型甲状腺癌:回顾性评估中的耐受性重点
Pharmaceuticals (Basel). 2025 Mar 21;18(4):443. doi: 10.3390/ph18040443.
4
Assessment of oral health-related quality of life and oral side effects of radioactive iodine therapy.放射性碘治疗的口腔健康相关生活质量及口腔副作用评估。
Clin Oral Investig. 2025 Feb 8;29(2):121. doi: 10.1007/s00784-025-06201-y.
5
Biodosimetry, can it find its way to the nuclear medicine clinic?生物剂量测定法能进入核医学临床领域吗?
Front Nucl Med. 2023 Jul 25;3:1209823. doi: 10.3389/fnume.2023.1209823. eCollection 2023.
6
Revisiting the Relationship Between Tumor Size and Risk in Well-Differentiated Thyroid Cancer.重新审视高分化甲状腺癌肿瘤大小与风险之间的关系。
Thyroid. 2024 Aug;34(8):980-989. doi: 10.1089/thy.2023.0327. Epub 2024 Jul 24.
7
Ultrasound and Sialendoscopy Findings in Radioactive Iodine-Induced Sialadenitis: Comparative Analysis and Possible Impact on Management.放射性碘诱发涎腺炎的超声和涎腺内镜检查结果:对比分析及对治疗的可能影响
J Clin Med. 2024 Jan 23;13(3):657. doi: 10.3390/jcm13030657.
8
Prophylactic effect of pilocarpine on acute sialadenitis following radioactive iodine therapy in thyroid cancer patients.毛果芸香碱预防甲状腺癌患者放射性碘治疗后急性涎腺炎的效果。
Int J Med Sci. 2024 Jan 1;21(3):492-495. doi: 10.7150/ijms.84590. eCollection 2024.
9
An Update on Alopecia and its Association With Thyroid Autoimmune Diseases.斑秃及其与甲状腺自身免疫性疾病关联的最新进展
touchREV Endocrinol. 2023 Nov;19(2):54-59. doi: 10.17925/EE.2023.19.2.10. Epub 2023 Aug 8.
10
A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.对伴有骨转移的分化型甲状腺癌患者,将总累积 I-131 活度提高至 37GBq 的长期回顾性基于队列的风险-获益分析。
PLoS One. 2023 Nov 14;18(11):e0294343. doi: 10.1371/journal.pone.0294343. eCollection 2023.